Sivik Global Healthcare’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.57M | Hold |
25,000
| – | – | 1.95% | 29 |
|
|
2026
Q1 | $2.57M | Sell |
25,000
-15,000
| -38% | -$1.69M | 1.95% | 29 |
|
|
2025
Q4 | $5.01M | Buy |
40,000
+2,500
| +7% | +$318K | 1.45% | 23 |
|
|
2025
Q3 | $5.02M | Sell |
37,500
-1,700
| -4% | -$223K | 1.46% | 26 |
|
|
2025
Q2 | $5.33M | Sell |
39,200
-5,800
| -13% | -$765K | 1.45% | 27 |
|
|
2025
Q1 | $5.97M | Sell |
45,000
-5,000
| -10% | -$636K | 3.23% | 17 |
|
|
2024
Q4 | $5.66M | Sell |
50,000
-10,000
| -17% | -$1.16M | 2.98% | 14 |
|
|
2024
Q3 | $6.84M | Buy |
+60,000
| New | +$6.58M | 2.9% | 14 |
|
|
2024
Q2 | – | Sell |
-50,000
| Closed | -$5.68M | – | 39 |
|
|
2024
Q1 | $5.68M | Sell |
50,000
-2,500
| -5% | -$287K | 1.33% | 20 |
|
|
2023
Q4 | $5.78M | Buy |
+52,500
| New | +$5.25M | 2.41% | 22 |
|
|
2023
Q3 | – | Sell |
-60,000
| Closed | -$6.54M | – | 34 |
|
|
2023
Q2 | $6.54M | Buy |
60,000
+15,000
| +33% | +$1.6M | 1.53% | 21 |
|
|
2023
Q1 | $4.56M | Hold |
45,000
| – | – | 1.96% | 29 |
|
|
2022
Q4 | $4.94M | Buy |
45,000
+15,000
| +50% | +$1.55M | 2.32% | 24 |
|
|
2022
Q3 | $2.9M | Sell |
30,000
-10,000
| -25% | -$1.07M | 1.61% | 30 |
|
|
2022
Q2 | $4.35M | Sell |
40,000
-5,000
| -11% | -$568K | 2.47% | 19 |
|
|
2022
Q1 | $5.33M | Sell |
45,000
-5,000
| -10% | -$620K | 2.2% | 21 |
|
|
2021
Q4 | $7.04M | Sell |
50,000
-20,000
| -29% | -$2.56M | 3.02% | 13 |
|
|
2021
Q3 | $8.27M | Buy |
70,000
+20,000
| +40% | +$2.46M | 1.98% | 17 |
|
|
2021
Q2 | $5.8M | Sell |
50,000
-15,000
| -23% | -$1.75M | 1.13% | 26 |
|
|
2021
Q1 | $7.79M | Sell |
65,000
-10,000
| -13% | -$1.18M | 2.84% | 14 |
|
|
2020
Q4 | $8.21M | Sell |
75,000
-15,000
| -17% | -$1.63M | 3.35% | 9 |
|
|
2020
Q3 | $9.79M | Buy |
90,000
+65,000
| +260% | +$6.59M | 4.21% | 1 |
|
|
2020
Q2 | $1.93M | Sell |
25,000
-40,000
| -62% | -$3.62M | 0.64% | 49 |
|
|
2020
Q1 | $5M | Buy |
65,000
+5,000
| +8% | +$417K | 1.97% | 23 |
|
|
2019
Q4 | $5.21M | Sell |
60,000
-20,000
| -25% | -$1.68M | 1.93% | 30 |
|
|
2019
Q3 | $6.69M | Hold |
80,000
| – | – | 3.38% | 7 |
|
|
2019
Q2 | $6.73M | Sell |
80,000
-20,000
| -20% | -$1.57M | 1.63% | 9 |
|
|
2019
Q1 | $7.99M | Sell |
100,000
-15,000
| -13% | -$1.12M | 2.95% | 5 |
|
|
2018
Q4 | $8.32M | Hold |
115,000
| – | – | 4.48% | 1 |
|
|
2018
Q3 | $8.44M | Buy |
115,000
+20,000
| +21% | +$1.31M | 3.01% | 6 |
|
|
2018
Q2 | $5.79M | Sell |
95,000
-40,000
| -30% | -$2.43M | 2.23% | 19 |
|
|
2018
Q1 | $8.09M | Buy |
135,000
+25,000
| +23% | +$1.51M | 3.77% | 1 |
|
|
2017
Q4 | $6.28M | Sell |
110,000
-30,000
| -21% | -$1.66M | 2.33% | 14 |
|
|
2017
Q3 | $7.47M | Buy |
140,000
+40,000
| +40% | +$2.01M | 2.54% | 13 |
|
|
2017
Q2 | $4.86M | Hold |
100,000
| – | – | 1.78% | 24 |
|
|
2017
Q1 | $4.44M | Buy |
+100,000
| New | +$4.32M | 2.07% | 23 |
|
|
2016
Q2 | – | Sell |
-125,000
| Closed | -$5.23M | – | 57 |
|
|
2016
Q1 | $5.23M | Buy |
+125,000
| New | +$4.95M | 2.31% | 16 |
|
|
2015
Q2 | – | Sell |
-50,000
| Closed | -$2.32M | – | 71 |
|
|
2015
Q1 | $2.32M | Buy |
+50,000
| New | +$2.3M | 0.79% | 56 |
|
Other funds holding ABT
WT
RG
DC
ATO
MMC
Sivik Global Healthcare's ABT Position: Q2 2026 in Review
Sivik Global Healthcare held its Abbott (ABT) position steady in Q2 2026 at 25,000 shares worth $2.57M. The position accounts for 1.95% of the portfolio, ranked #29.
Sivik Global Healthcare first reported a position in ABT in Q1 2015 and has held it in 38 quarters since. The position peaked at $9.79M in Q3 2020. 940 funds tracked by Wall St. Rank hold ABT as of Q2 2026.
- Sivik Global Healthcare held 25,000 shares of Abbott worth $2.57M as of Q2 2026.
- Sivik Global Healthcare left its Abbott share count unchanged in Q2 2026.
- Abbott made up 1.95% of Sivik Global Healthcare's portfolio in Q2 2026, its #29 holding.
- Sivik Global Healthcare first reported a position in Abbott in Q1 2015 and has held it in 38 quarters since.
- Sivik Global Healthcare's Abbott position peaked at $9.79M in Q3 2020.
- 940 funds tracked by Wall St. Rank held Abbott as of Q2 2026.
Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.